Inventor
Rashida A. Karmali
Inventor
Brooklyn, NY, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds14%
C07HSugars7%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
A42CManufacturing or trimming head coverings, e.g. hats2%
A61BDiagnosis2%
B01LChemical or physical laboratory apparatus for general use2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,378,059Methods and molecular pharmacodynamic biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate20199,089,570'Compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate'20158,912,223'Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulations'20148,877,785'Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate'20148,802,831'Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt'20148,420,658'Use of Carboxyamidotriazole (CAI) orotate in macular degeneration'20138,415,388'Pharmaceutical compositions containing paclitaxel orotate'20138,377,973'Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations'20138,148,339'Method of reducing cardiac levels of doxorubicin when given as orotate salt'20128,034,823'Method of increasing drug oral bioavailability and compositions of less toxic orotate salts'20117,750,018'Use of carboxiamidotriazole (CAI) orotate in macular degeneration'20107,601,834'Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives'20097,470,672'Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives'20087,378,054'Specimen collecting, processing and analytical assembly'2008D0465641'Cool cap'20026,243,876'Kool cap'20016,239,137'Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity'20016,184,227'Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2014Patents assigned to SAVVIPHARM INC (9)· patent assignee history
2001–2011Based in New York, NY, US· patent location history
2008–2019Based in Brooklyn, NY, US· patent location history
2010–2019Patents assigned to TACTICAL THERAPEUTICS INC (7)· patent assignee history
2012–2019Patents assigned to KARMALI RASHIDA A (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KARMALI RASHIDA Aself | 9 | 2012–2019 |
| SAVVIPHARM INC | 9 | 2001–2014 |
| TACTICAL THERAPEUTICS INC | 7 | 2010–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Brooklyn, New York, US | 12 | 2008–2019 |
| New York, New York, US | 6 | 2001–2011 |